| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9774 | 
      | Human Intestinal Absorption | HIA+ | 0.9684 | 
      | Caco-2 Permeability | Caco2+ | 0.8609 | 
      | P-glycoprotein Substrate | Substrate | 0.8572 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8438 | 
                                                     | Inhibitor | 0.6867 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.6996 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.7225 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7921 | 
      | CYP450 2D6 Substrate | Substrate | 0.7890 | 
      | CYP450 3A4 Substrate | Substrate | 0.5875 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9412 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9188 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9302 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.7193 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9286 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7449 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9242 | 
                                                                    | Inhibitor | 0.8222 | 
      | AMES Toxicity | Non AMES toxic | 0.9180 | 
      | Carcinogens | Non-carcinogens | 0.9297 | 
      | Fish Toxicity | High FHMT | 0.9459 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9444 | 
      | Honey Bee Toxicity | Low HBT | 0.7947 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | II | 0.4949 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7437 |